| Overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: a randomized trial F Rosqvist, J Kullberg, M Ståhlman, J Cedernaes, K Heurling, ... The Journal of Clinical Endocrinology & Metabolism 104 (12), 6207-6219, 2019 | 195 | 2019 |
| [18F] flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-β pathology DR Thal, TG Beach, M Zanette, K Heurling, A Chakrabarty, A Ismail, ... Alzheimer's & Dementia 11 (8), 975-985, 2015 | 139 | 2015 |
| Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection MD Ikonomovic, CJ Buckley, K Heurling, P Sherwin, PA Jones, M Zanette, ... Acta neuropathologica communications 4, 1-24, 2016 | 102 | 2016 |
| Update on biomarkers for amyloid pathology in Alzheimer’s disease NJ Ashton, M Schöll, K Heurling, E Gkanatsiou, E Portelius, K Höglund, ... Biomarkers in medicine 12 (7), 799-812, 2018 | 77 | 2018 |
| Synaptic vesicle protein 2A as a potential biomarker in synaptopathies K Heurling, NJ Ashton, A Leuzy, ER Zimmer, K Blennow, H Zetterberg, ... Molecular and Cellular Neuroscience 97, 34-42, 2019 | 73 | 2019 |
| Altered glucose uptake in muscle, visceral adipose tissue, and brain predict whole-body insulin resistance and may contribute to the development of type 2 diabetes: a combined … GJ Boersma, E Johansson, MJ Pereira, K Heurling, S Skrtic, J Lau, ... Hormone and metabolic research 50 (08), 627-639, 2018 | 66 | 2018 |
| Effects of 6 weeks of treatment with dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: a … J Oldgren, S Laurila, A Åkerblom, A Latva‐Rasku, E Rebelos, H Isackson, ... Diabetes, Obesity and Metabolism 23 (7), 1505-1517, 2021 | 60 | 2021 |
| Quantitative positron emission tomography in brain research K Heurling, A Leuzy, M Jonasson, A Frick, ER Zimmer, A Nordberg, ... Brain research 1670, 220-234, 2017 | 57 | 2017 |
| Imaging β-amyloid using [18F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis K Heurling, A Leuzy, ER Zimmer, M Lubberink, A Nordberg European journal of nuclear medicine and molecular imaging 43, 362-373, 2016 | 48 | 2016 |
| Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition DR Thal, TG Beach, M Zanette, J Lilja, K Heurling, A Chakrabarty, A Ismail, ... Acta neuropathologica 136, 557-567, 2018 | 47 | 2018 |
| Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies F Heeman, M Yaqub, I Lopes Alves, K Heurling, J Berkhof, JD Gispert, ... EJNMMI research 9, 1-14, 2019 | 46 | 2019 |
| Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients V Leinonen, JO Rinne, KA Virtanen, O Eskola, J Rummukainen, ... European Journal of Neurology 20 (7), 1043-1052, 2013 | 46 | 2013 |
| Focus: medical technology: in vivo detection of Alzheimer’s disease A Leuzy, K Heurling, NJ Ashton, M Schöll, ER Zimmer The Yale Journal of Biology and Medicine 91 (3), 291, 2018 | 43 | 2018 |
| (18) F] flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-beta pathology … DR Thal, TG Beach, M Zanette, K Heurling, A Chakrabarty, A Ismail, ... Google Scholar, 0 | 43 | |
| Serotonin synthesis rate and the tryptophan hydroxylase-2: G-703T polymorphism in social anxiety disorder T Furmark, I Marteinsdottir, A Frick, K Heurling, M Tillfors, L Appel, ... Journal of psychopharmacology 30 (10), 1028-1035, 2016 | 41 | 2016 |
| Use of amyloid PET across the spectrum of Alzheimer’s disease: clinical utility and associated ethical issues A Leuzy, ER Zimmer, K Heurling, P Rosa-Neto, S Gauthier Amyloid 21 (3), 143-148, 2014 | 41 | 2014 |
| Whole-body imaging of tissue-specific insulin sensitivity and body composition by using an integrated PET/MR system: a feasibility study E Johansson, M Lubberink, K Heurling, JW Eriksson, S Skrtic, H Ahlström, ... Radiology 286 (1), 271-278, 2018 | 40 | 2018 |
| Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia DR Thal, A Ronisz, T Tousseyn, A Rijal Upadhaya, K Balakrishnan, ... Acta neuropathologica communications 7, 1-16, 2019 | 36 | 2019 |
| Parametric imaging and quantitative analysis of the PET amyloid ligand [18F] flutemetamol K Heurling, C Buckley, K Van Laere, R Vandenberghe, M Lubberink Neuroimage 121, 184-192, 2015 | 28 | 2015 |
| Diagnostic effectiveness of quantitative [18F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of … V Leinonen, JO Rinne, DF Wong, DA Wolk, JQ Trojanowski, PF Sherwin, ... Acta neuropathologica communications 2, 1-22, 2014 | 25 | 2014 |
